A6. New drug development (formerly L3)
Poster Session: New Drug Development
Andrew Shorr, MD, MPH, MBA
Section Director, Pulmonary and Critical Care Medicine
Medstar Washington Hospital Center, United States
Keith S. Kaye, MD, MPH
Professor of Medicine
Rutgers Robert Wood Johnson Medical School
New Brunswick, NJ, United States
Marya D. Zilberberg, MD, MPH (she/her/hers)
President & CEO
EviMed Research Group, LLC
Goshen, Massachusetts, United States
Judith N. Steenbergen, PhD
CEO
Scientific and Medical Affairs Consulting, LLC
Washington Crossing, Pennsylvania, United States
Surya Chitra, PhD
Savio Group Analytics
Hockessin, Delaware, United States
Lauren Bjork, PharmD
Medical Science Liaison
Meitheal Pharmaceuticals
Chicago, IL, United States
Mauricio Rodriguez, PharmD, MS-HEOR, BCCCP, BCIDP
Sr Medical Science Liaison, Medical Affairs
Meitheal Pharmaceuticals
Austin, TX, United States